Clene Quote - CLNN

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

5.55

Bid

5.51

Ask

5.66

Volume

164,036

5.25 Day's Range 5.67

3.8181 52 Week Range 11.00

Market Cap

44.287M

Previous Close

5.34

Open

5.43

Last Trade

5.5001

Last Trade Time

Financial Volume

US$ 903,615

VWAP

5.5086

Average Volume (3m)

79,242

Shares Outstanding

7,979,726

Dividend Yield

PE Ratio

-0.89

Earnings Per Share (EPS)

-6.2

Revenue

654k

Net Profit

-49.5M

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development a... Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development and commercialization of novel clean-surfaced nanotechnology therapeutics (Drugs, and (2) the development and commercialization of dietary supplements (Supplements). Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.clene.com

Headquarters

Dover, Delaware, USA

Founded

Clene Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CLNN. The last closing price for Clene was US$5.34. Over the last year, Clene shares have traded in a share price range of US$ 3.8181 to US$ 11.00.

Clene currently has 7,979,726 shares outstanding. The market capitalization of Clene is US$42.61 million. Clene has a price to earnings ratio (PE ratio) of -0.89.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.6548	13.3763686877	4.8952	5.66	4.81	79671	5.27112934	CS
4	0.89	19.0987124464	4.66	5.66	4.04	95028	4.89570971	CS
12	-0.06	-1.06951871658	5.61	6.5	3.85	79242	4.83453156	CS
26	-1.45	-20.7142857143	7	7	3.8181	137838	5.33402843	CS
52	-0.43	-7.19063545151	5.98	11	3.8181	472032	7.50072808	CS
156	-75.45	-93.1481481481	81	102.6	3.8181	536768	29.34819926	CS
260	-185.45	-97.0942408377	191	356.4	3.8181	468129	54.02135487	CS

CLNN - Frequently Asked Questions (FAQ)

What is the current Clene share price?

The current share price of Clene is US$ 5.55

How many Clene shares are in issue?

Clene has 7,979,726 shares in issue

What is the market cap of Clene?

The market capitalisation of Clene is USD 42.61M

What is the 1 year trading range for Clene share price?

Clene has traded in the range of US$ 3.8181 to US$ 11.00 during the past year

What is the PE ratio of Clene?

The price to earnings ratio of Clene is -0.89

What is the cash to sales ratio of Clene?

The cash to sales ratio of Clene is 67.56

What is the reporting currency for Clene?

Clene reports financial results in USD

What is the latest annual turnover for Clene?

The latest annual turnover of Clene is USD 654k

What is the latest annual profit for Clene?

The latest annual profit of Clene is USD -49.5M

What is the registered address of Clene?

The registered address for Clene is 3500 S DUPONT HWY, KENT, DOVER, DELAWARE, 19901

What is the Clene website address?

The website address for Clene is www.clene.com

Which industry sector does Clene operate in?

Clene operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BOXLBoxlight Corporation	US$ 1.645 (257.61%)	240.3M
SPRCSciSparc Ltd	US$ 1.06 (100.80%)	189.11M
XTIAXTI Aerospace Inc	US$ 0.08261 (99.54%)	1.55B
DHAIDIH Holdings US Inc	US$ 2.8602 (82.18%)	4.62M
NXPLNextPlat Corporation	US$ 1.73 (61.68%)	12.6M
RGFReal Good Food Company Inc	US$ 1.31 (-63.49%)	1.47M
LUNALuna Innovations Incorporated	US$ 0.8744 (-57.35%)	12.29M
GCTKGlucoTrack Inc	US$ 0.1594 (-45.65%)	35.68M
ACONAclarion Inc	US$ 0.1699 (-43.06%)	35.02M
BLRXBioLineRx Ltd	US$ 0.1621 (-40.80%)	44.6M
XTIAXTI Aerospace Inc	US$ 0.08261 (99.54%)	1.55B
NVDANVIDIA Corporation	US$ 149.43 (3.43%)	264.21M
CNSPCNS Pharmaceuticals Inc	US$ 0.11987 (-2.54%)	246.57M
BOXLBoxlight Corporation	US$ 1.645 (257.61%)	240.3M
SPRCSciSparc Ltd	US$ 1.06 (100.80%)	190.36M